Axonics, Inc. Common Stock
AXNX
AXNX was delisted on the 14th of November, 2024.
103 hedge funds and large institutions have $565M invested in Axonics, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 42 increasing their positions, 10 reducing their positions, and 15 closing their positions.
320% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 10
203% more call options, than puts
Call options by funds: $3.38M | Put options by funds: $1.11M
147% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 15
116% more capital invested
Capital invested by funds: $261M → $565M (+$304M)
27% more funds holding
Funds holding: 81 → 103 (+22)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$40.2M |
| 2 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$21.4M |
| 3 |
DM
Deerfield Management
New York
|
+$20M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
+$17.2M |
| 5 |
PCM
Peregrine Capital Management
Minneapolis,
Minnesota
|
+$14.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$9.29M |
| 2 |
EI
EAM Investors
Solana Beach,
California
|
-$2.23M |
| 3 |
SG Americas Securities
New York
|
-$1.85M |
| 4 |
EGI
EAM Global Investors
Solana Beach,
California
|
-$1.67M |
| 5 |
Two Sigma Investments
New York
|
-$1.27M |
AXNX Hedge Fund Activity: Q4 2019 in Review
103 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Axonics, Inc. Common Stock (AXNX) for Q4 2019, worth a combined $565M — up 116% from $261M a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new AXNX positions and 15 closed out — a net gain of 22 holders — while 42 added to existing stakes and 10 trimmed.
The largest buyer was Millennium Management, adding an estimated $40.2M. The largest seller was Fidelity Investments, cutting an estimated $9.29M.
- 103 institutional investors held Axonics, Inc. Common Stock (AXNX) as of Q4 2019, up from 81 in Q3 2019.
- Funds reported $565M of Axonics, Inc. Common Stock stock for Q4 2019, up 116% quarter-over-quarter.
- 37 funds opened new Axonics, Inc. Common Stock positions in Q4 2019 and 15 closed out, a net change of +22 holders.
- The largest Axonics, Inc. Common Stock buyer in Q4 2019 was Millennium Management, an estimated $40.2M added.
- The largest Axonics, Inc. Common Stock seller in Q4 2019 was Fidelity Investments, an estimated $9.29M sold.
Based on aggregated 13F filings for Q4 2019.